A murine study used induced hyperlipidemia to investigate the effects of a high-fat diet on the meibomian gland in mice. Source: AAO
This week in the news, increases in myopia may lead to increased myopic macular degeneration, severe chronic kidney disease puts patients at risk for glaucoma, and glaucoma medication adherence is linked to racial and ethnic disparities. Source: AAO
Results from Archway, a phase 3 trial that assessed the Port Delivery System vs. intravitreal ranibizumab, showed that the implant was noninferior and offered equivalent efficacy to monthly injections. Source: AAO
A global survey of retinoblastoma specialists aimed to identify the definition of high-risk retinoblastoma and there was significant variability in what current treatment criteria were included from nation to nation. Source: AAO
Following an outbreak of COVID-19–associated rhino-orbital cerebral mucormycosis (RCOM), Indian investigators conducted a retrospective case-control study to determine mortality rates for patients presenting with RCOM and risk factors for the condition. Source: AAO
The use of dural venous sinus stenting (DVSS) in patients with idiopathic intracranial hypertension (IIH) should be based on the patient’s characteristics, disease progression, and physician expertise. Source: AAO
This population-based, retrospective case series study of patients enrolled in the Rochester Epidemiology Project evaluated the association of stroke in the 15 days before and after central retinal artery occlusion (CRAO). Source: AAO
This chart review identified patients with glaucoma or ocular surface disease who were fitted with a Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) device and how those with glaucoma responded. Source: AAO
Investigators compared the preferred practice of treating amblyopia with sequential treatment (glasses, then occlusion) with simultaneous treatment (glasses and occlusion together). Source: AAO
This week in the news, ophthalmologists report pandemic-related burnout and stress, a phase 3 trial of cenegermin for severe Sjögren-related dry eye disease is enrolling patients, and higher corneal nerve loss is seen with increased painful diabetic neuropathy. Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »
